Core Viewpoint - EuroDry (EDRY) has shown a significant price increase of 56.8% over the past four weeks, with a mean price target of $29.33 indicating a potential upside of 45.2% from the current trading price of $20.2 [1] Price Targets and Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $4.51, where the lowest estimate of $25.00 suggests a 23.8% increase, and the highest estimate of $34.00 indicates a potential surge of 68.3% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Analyst Sentiment and Earnings Estimates - Analysts are optimistic about EDRY's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which has shown a correlation with near-term stock price movements [11] - The Zacks Consensus Estimate for the current year has increased by 104.1% over the past month, with no negative revisions, indicating positive sentiment among analysts [12] - EDRY holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, further supporting the stock's potential upside [13] Caution on Price Targets - While consensus price targets are often sought after, they may not reliably indicate actual stock price movements, and investors should approach them with skepticism [3][10]

Core Viewpoint - GeneDx Holdings Corp. (WGS) has seen a 4.5% increase in share price over the past four weeks, closing at $88.11, with analysts suggesting a potential upside of 77.8% based on a mean price target of $156.67 [1] Price Targets - The average price target consists of nine estimates ranging from a low of $130.00 to a high of $177.00, with a standard deviation of $16.54, indicating a potential increase of 47.5% to 100.9% from the current price [2] - A low standard deviation suggests a strong agreement among analysts regarding the price targets, which can be a positive indicator for investors [2][9] Analyst Sentiment - There is a growing optimism among analysts regarding WGS's earnings prospects, supported by a trend of upward revisions in earnings estimates, which historically correlates with stock price movements [11] - The Zacks Consensus Estimate for the current year has risen by 29.3% over the past month, with no negative revisions, indicating strong analyst confidence [12] Zacks Rank - WGS holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, further supporting the stock's potential upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the stock's potential gain, the implied direction of price movement appears to be a useful guide for investors [14]

Core Viewpoint - Onto Innovation (ONTO) shows potential for significant upside, with a mean price target of $252.5 indicating a 28.2% increase from the current price of $196.89 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $44, suggesting variability in analyst predictions [2] - The lowest estimate is $160.00, indicating an 18.7% decline, while the highest estimate is $300.00, reflecting a potential increase of 52.4% [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7] Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding ONTO's ability to report better earnings, which supports the expectation of stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 5.6% over the past month, with four estimates revised higher and no negative revisions [12] - ONTO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of potential gains, the direction implied by these targets appears to be a useful guide for further research [14]

Core Viewpoint - Accel Entertainment (ACEL) shares have increased by 9.1% recently, with a mean price target of $15.5 suggesting a potential upside of 27.2% from the current price of $12.19 [1] Price Targets - The average price target consists of six estimates ranging from a low of $14.00 to a high of $17.00, with a standard deviation of $1.22, indicating a relatively tight clustering of analyst estimates [2] - The lowest estimate suggests a 14.9% increase, while the highest indicates a 39.5% upside [2] Analyst Sentiment - Analysts show strong agreement in revising earnings estimates higher, which historically correlates with positive stock price movements [4][11] - For the current year, one estimate has increased over the last 30 days, leading to a 1.9% rise in the Zacks Consensus Estimate [12] Zacks Rank - ACEL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to potential biases among analysts [3][10] - A low standard deviation among price targets suggests a high degree of agreement among analysts, which can be a useful starting point for further research [9]

Company Overview - Stevanato Group S.p.A. is a leading entity in the pharmaceutical and healthcare industry, known for its production of glass containers and integrated systems for drug delivery, with a strong global presence and innovative solutions [1] Financial Performance - The recent Q4 2025 earnings call provided insights into Stevanato Group's financial performance, discussing revenue, profit margins, and future outlook, which are crucial for understanding the company's operational strategies and market conditions [3] - Stevanato Group's market capitalization stands at approximately $4.37 billion, with a trading volume of 388,631 shares, indicating significant stock volatility over the past year [4][5] Stock Performance - Paul Knight from KeyBanc set a price target of $32 for STVN, suggesting a potential price increase of approximately 99.88%, while the stock is currently priced at $15.99, reflecting a decrease of 8.63% today [2][5] - Over the past year, the stock has reached a high of $28 and a low of $13.91, indicating the potential for significant price movements [4]

Core Viewpoint - Palantir Technologies Inc. (PLTR) shows potential for further upside, with a mean price target of $200.41 indicating a 30.8% increase from its current price of $153.19, following a 9.8% gain over the past four weeks [1]. Price Targets and Analyst Estimates - The mean estimate consists of 22 short-term price targets with a standard deviation of $33.93, indicating variability among analysts. The lowest estimate is $90.00 (41.3% decline), while the highest is $260.00 (69.7% increase) [2]. - A low standard deviation suggests a strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about PLTR's earnings prospects, with nine estimates revised higher in the last 30 days and no negative revisions, leading to a 26.3% increase in the Zacks Consensus Estimate [12]. - PLTR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]. Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research indicates that they rarely predict actual stock price movements accurately [7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8].

Core Viewpoint - Enovis (ENOV) shares have increased by 13.1% in the past four weeks, closing at $25.79, with a mean price target of $45.55 indicating a potential upside of 76.6% according to Wall Street analysts [1] Group 1: Price Targets and Analyst Estimates - The mean estimate consists of 11 short-term price targets with a standard deviation of $6.47, where the lowest estimate is $33.00 (28% increase) and the highest is $55.00 (113.3% increase) [2] - Analysts' consensus on price targets is often questioned, as their ability to set unbiased targets has been historically unreliable [3][7] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Group 2: Earnings Estimates and Market Sentiment - Analysts are optimistic about ENOV's earnings prospects, as indicated by a strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the past 30 days, one estimate has increased with no negative revisions, leading to an 11.2% rise in the Zacks Consensus Estimate for the current year [12] - ENOV holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13]

Core Viewpoint - Global-e Online Ltd. (GLBE) has seen a 2.2% increase in shares over the past four weeks, closing at $34.64, with analysts suggesting a potential upside of 41.2% based on a mean price target of $48.92 [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $6.93, indicating variability among analysts; the lowest estimate is $40.00 (15.5% increase), while the highest is $64.00 (84.8% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can be a useful starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts show strong agreement in revising earnings estimates higher for GLBE, which correlates with potential stock price increases; the Zacks Consensus Estimate for the current year has risen by 14.8% over the last 30 days, with four estimates moving higher and no negative revisions [11][12] - GLBE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [13] Caution on Price Targets - While price targets are often sought after by investors, they can be misleading; empirical research indicates that analysts' price targets rarely reflect actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Group 1 - Monro Muffler Brake (MNRO) closed at $20.07, with a 6.4% gain over the past four weeks, and a mean price target of $25.63 suggests a 27.7% upside potential [1] - The mean estimate includes four short-term price targets with a standard deviation of $10.08, indicating variability among analysts; the lowest estimate is $17.50 (12.8% decline), while the highest is $40.00 (99.3% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases, as indicated by a 1.8% increase in the Zacks Consensus Estimate for the current year [4][12] Group 2 - MNRO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [13] - While price targets are often viewed skeptically due to potential biases from analysts, the direction indicated by these targets may still serve as a useful guide for investors [10][14] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can be a starting point for further research [9]

Core Viewpoint - Replimune Group, Inc. (REPL) has seen a 2.7% increase in share price over the past four weeks, closing at $7.16, with analysts suggesting a potential upside of 79.6% based on a mean price target of $12.86 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $10.00 to a high of $19.00, with a standard deviation of $3.02, indicating variability among analysts [2] - The lowest estimate suggests a 39.7% increase from the current price, while the highest estimate indicates a 165.4% upside [2] Analyst Sentiment - Analysts show strong agreement regarding REPL's ability to exceed previous earnings predictions, which supports the expectation of a stock price increase [4][11] - The Zacks Consensus Estimate for the current year has risen by 5% over the past month, with four estimates increasing and no negative revisions [12] Zacks Rank - REPL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to historical inaccuracies in predicting stock price movements [3][7][10]